Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
21.80Prev. Close
21.96Volume
6,042Total traded value
0.01 CrUpper Circuit
26.35Lower Circuit
17.57Fundamentals
| Market Cap | ₹95Cr |
| ROE | -22.95% |
| P/E Ratio(TTM) | -5.25 |
| EPS(TTM) | -4.18 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.61 |
| Book Value | -7.54 |
| Debt to Equity | 0.94 |
| Face Value | 10 |
Understand Fundamentals
Financials
About BIBCOL
Bharat Immunologicals & Biologicals Corporation, a government company, manufactures life-saving Oral Polio Vaccine for India's national immunization program. It is diversifying its product line by developing other crucial vaccines, including one for Oral Cholera. Since its inception, the company has significantly contributed by supplying billions of doses of Oral Polio Vaccine.;
| Parent Organisation | Bharat Immunologicals & Biologicals Corporation Limited |
| Managing Director | Dr. Sanjay Mishra |
| BSE Symbol | 524663 |
Shareholding Pattern
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.29 | ||
| Gland Pharma | NA (0.00%) | 43.15 | ||
| Ajanta Pharma | NA (0.00%) | 34.21 | ||
| Eris Lifesciences | NA (0.00%) | 57.62 |